ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
194,000
+2,900 (1.52%)
At close: Feb 27, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Biotechnology (Startups)
33.40B65.55B67.30B5.33B
Biotechnology (Startups) Growth
-49.04%-2.61%1162.19%-
Total
33.40B65.55B67.30B5.33B
Total Growth
-49.04%-2.61%1162.19%-

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
South Korea
300.00M2.00B2.38B483.55M
South Korea Growth
-84.97%-16.30%393.11%-
United States
33.10B63.55B62.32B4.85B
United States Growth
-47.91%1.98%1185.24%-
China
--2.60B-
Total
33.40B65.55B67.30B5.33B
Total Growth
-49.04%-2.61%1162.19%-
Source: S&P Global Market Intelligence.